Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures.

about

Observational study of the bisphosphonate-related osteonecrosis of jaws.

P2860

Q55237271-E05550E0-46F3-4B7A-838F-3888E0ADB5CE

P2860

Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures.

Item

http://www.wikidata.org/entity/Q39013177

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Denosumab: Prevention and mana ...... he jaw and atypical fractures.

@en

Denosumab: Prevention and mana ...... he jaw and atypical fractures.

@nl

type

Item

label

Denosumab: Prevention and mana ...... he jaw and atypical fractures.

@en

Denosumab: Prevention and mana ...... he jaw and atypical fractures.

@nl

prefLabel

Denosumab: Prevention and mana ...... he jaw and atypical fractures.

@en

Denosumab: Prevention and mana ...... he jaw and atypical fractures.

@nl

P1476

Denosumab: Prevention and mana ...... he jaw and atypical fractures.

@en

P2093

Amanda Goldrick

http://www.w3.org/2001/XMLSchema#string

Jeffrey Goh

http://www.w3.org/2001/XMLSchema#string

Kenneth Pittman

http://www.w3.org/2001/XMLSchema#string

Richard H de Boer

http://www.w3.org/2001/XMLSchema#string

Yoland C Antill

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus

The clinical approach toward giant cell tumor of bone

American Society of Biomechanics Journal of Biomechanics Award 2013: cortical bone tissue mechanical quality and biological mechanisms possibly underlying atypical fractures.

Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials

Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors.

Diagnosis and management of hypocalcaemia

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.

Systematic literature review and network meta-analysis comparing bone-targeted agents for the prevention of skeletal-related events in cancer patients with bone metastasis

The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study

Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer

P304

266-276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJCO.12517

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27862983

http://www.w3.org/2001/XMLSchema#string

Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures.

about

P2860

P2860

Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698